IDEXX Laboratories, Inc. (IDXX) vs Medline Inc. (MDLN)
A side-by-side comparison of IDEXX Laboratories, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
IDXX
IDEXX Laboratories, Inc.
$569.77HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
MDLN
Medline Inc.
$40.08HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
Total return — IDXX vs MDLN
growth of $100 · dividends reinvested · last 1yIDXX -19.1%MDLN -1.2%MDLN compounded faster
IDXX MDLN
IDXX vs MDLN: by the numbers
- •IDXX is the larger company ($44.95B vs $33.89B market cap).
- •MDLN trades at the lower trailing earnings multiple (33.48 vs 42.00 P/E), one valuation lens rather than an overall verdict.
- •IDXX converts more revenue to profit (24.63% vs 3.31% net margin).
Metrics side by side
Valuation
| Metric | IDXX | MDLN |
|---|---|---|
| P/E ratio | 42.00 | 33.48 |
| Forward P/E | 38.89 | 26.74 |
| P/S ratio | 10.33 | 1.15 |
| P/B ratio | 29.53 | 2.96 |
| PEG ratio | 2.31 | N/A |
| EV / EBITDA | 30.13 | 14.69 |
| FCF yield | 2.35% | 4.56% |
Profitability
| Metric | IDXX | MDLN |
|---|---|---|
| Gross margin | 62.05% | 24.04% |
| Operating margin | 31.63% | 7.04% |
| Net margin | 24.63% | 3.31% |
| ROE | 70.38% | 8.55% |
| ROIC | 40.27% | 5.69% |
Growth (annualized)
| Metric | IDXX | MDLN |
|---|---|---|
| Revenue CAGR (5Y) | 9.24% | N/A |
| EPS CAGR (5Y) | 14.07% | N/A |
| FCF CAGR (5Y) | 10.13% | N/A |
| Total return CAGR (5Y) | -3.92% | N/A |
Frequently asked
- Which has the lower trailing P/E, IDXX or MDLN?
- MDLN has the lower trailing P/E: IDXX trades at 42.00 and MDLN at 33.48. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is IDXX or MDLN more profitable?
- IDXX runs the higher net margin — IDXX at 24.63% versus MDLN at 3.31%.
Go deeper
Dig into the metrics
IDEXX Laboratories P/E ratioMedline P/E ratioIDEXX Laboratories dividend yieldMedline dividend yieldIDEXX Laboratories ROEMedline ROEIDEXX Laboratories operating marginMedline operating marginIDEXX Laboratories revenue growthMedline revenue growthIDEXX Laboratories free cash flowMedline free cash flow
IDEXX Laboratories & Medline appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.